Search Results - "Inoue, Takako"
-
1
Novel biomarkers for the management of chronic hepatitis B
Published in Clinical and molecular hepatology (01-07-2020)“…Hepatitis B virus (HBV) cannot be eliminated completely from infected hepatocytes because of the presence of intrahepatic covalently closed circular DNA…”
Get full text
Journal Article Book Review -
2
The Role of Hepatitis B Core-Related Antigen
Published in Genes (09-05-2019)“…Hepatitis B virus (HBV) cannot be completely eliminated from infected hepatocytes due to the existence of intrahepatic covalently closed circular DNA (cccDNA)…”
Get full text
Journal Article -
3
Clinical efficacy of a novel, high-sensitivity HBcrAg assay in the management of chronic hepatitis B and HBV reactivation
Published in Journal of hepatology (01-08-2021)“…A fully automated, novel high-sensitivity hepatitis B core-related antigen assay (iTACT-HBcrAg) has been developed. We demonstrate the clinical utility of…”
Get full text
Journal Article -
4
Novel strategies for the early diagnosis of hepatitis B virus reactivation
Published in Hepatology research (01-10-2021)“…Hepatitis B virus (HBV) reactivation under systemic chemotherapy or immunosuppressive therapy is a serious complication among HBV‐resolved patients. Some…”
Get full text
Journal Article -
5
Novel Biomarkers of Hepatitis B and Hepatocellular Carcinoma: Clinical Significance of HBcrAg and M2BPGi
Published in International journal of molecular sciences (31-01-2020)“…The hepatitis B virus (HBV) cannot be removed completely from infected hepatocytes, owing to the presence of intrahepatic covalently closed circular DNA…”
Get full text
Journal Article -
6
Hepatitis B core-related antigen: A novel and promising surrogate biomarker to guide anti-hepatitis B virus therapy
Published in Clinical and molecular hepatology (01-10-2023)“…The current requirement for biomarkers to detect hepatitis B virus (HBV) infection is polarized. One is a fully-automated and highly sensitive measurement…”
Get full text
Journal Article Book Review -
7
Hepatitis B virus and its sexually transmitted infection - an update
Published in Microbial cell (05-09-2016)“…About 5% of the world's population has chronic hepatitis B virus (HBV) infection, and nearly 25% of carriers develop chronic hepatitis, cirrhosis, and…”
Get full text
Journal Article -
8
Cross-Protection of Hepatitis B Vaccination among Different Genotypes
Published in Vaccines (Basel) (16-08-2020)“…Hepatitis B (HB) vaccination is the most effective method for preventing HB virus (HBV) infection. Universal HB vaccination containing recombinant HB surface…”
Get full text
Journal Article -
9
Two Concepts of Hepatitis B Core-Related Antigen Assay: A Highly Sensitive and Rapid Assay or an Effective Tool for Widespread Screening
Published in Viruses (26-05-2024)“…Hepatitis B core-related antigen (HBcrAg) reflects the activity of intrahepatic covalently closed circular DNA. HBcrAg can be detected even in chronic…”
Get full text
Journal Article -
10
Metastatic site as a predictor of nivolumab efficacy in patients with advanced non-small cell lung cancer: A retrospective multicenter trial
Published in PloS one (22-02-2018)“…To conduct a retrospective multicenter trial to determine the significance of metastatic site as a predictor of nivolumab efficacy in patients with advanced…”
Get full text
Journal Article -
11
Diagnostic Accuracy of Noninvasive Genotyping of EGFR in Lung Cancer Patients by Deep Sequencing of Plasma Cell-Free DNA
Published in Clinical chemistry (Baltimore, Md.) (01-09-2015)“…Genotyping of EGFR (epidermal growth factor receptor) mutations is indispensable for making therapeutic decisions regarding whether to use EGFR tyrosine kinase…”
Get full text
Journal Article -
12
Clinical usefulness of a novel high-sensitivity hepatitis B core-related antigen assay to determine the initiation of treatment for HBV reactivation
Published in Journal of gastroenterology (01-07-2022)“…Backgrounds A fully automated, novel, high-sensitivity hepatitis B core-related antigen assay (iTACT-HBcrAg) has been developing. The purpose of this study is…”
Get full text
Journal Article -
13
Monitoring of treatment responses and clonal evolution of tumor cells by circulating tumor DNA of heterogeneous mutant EGFR genes in lung cancer
Published in Lung cancer (Amsterdam, Netherlands) (01-04-2016)“…Highlights • EGFR ctDNA rapidly responded to an EGFR-TKI as a response predictor. • Transient ctDNA peaks of various EGFR mutants appeared during EGFR-TKI…”
Get full text
Journal Article -
14
Hepatitis B Core-Related Antigen and New Therapies for Hepatitis B
Published in Microorganisms (Basel) (02-10-2021)“…The hepatitis B core-related antigen (HBcrAg) is an unprecedented novel HBV biomarker that plays an essential role in reflecting covalently closed circular DNA…”
Get full text
Journal Article -
15
High levels of serum Mac-2-binding protein glycosylation isomer (M2BPGi) predict the development of hepatocellular carcinoma in hepatitis B patients treated with nucleot(s)ide analogues
Published in Journal of gastroenterology (01-07-2018)“…Background Nucleot(s)ide analogues (NA) can reduce the risk of hepatocellular carcinoma (HCC), but not completely prevent its development. Methods Two hundred…”
Get full text
Journal Article -
16
Gut dysbiosis associated with clinical prognosis of patients with primary biliary cholangitis
Published in Hepatology research (01-07-2020)“…Aim Although some relationships between gut microbiota and liver diseases have been reported, it remains uncertain whether changes in gut microbiota owing to…”
Get full text
Journal Article -
17
Dynamics of circulating tumor DNA represented by the activating and resistant mutations in epidermal growth factor receptor tyrosine kinase inhibitor treatment
Published in Cancer science (01-03-2016)“…Circulating tumor DNA (ctDNA) is an emerging field of cancer research. For lung cancer, non‐invasive genotyping of EGFR is the foremost application. The…”
Get full text
Journal Article -
18
Efficacy of anti-PD-1/PD-L1 antibodies after discontinuation due to adverse events in non-small cell lung cancer patients (HANSHIN 0316)
Published in BMC cancer (03-10-2018)“…Immune checkpoint inhibitors (ICIs) have emerged as promising therapeutic agents in non-small cell lung cancer (NSCLC). However, the duration for which ICIs…”
Get full text
Journal Article -
19
Management of hepatitis B virus (HBV) reactivation in patients with resolved HBV infection based on a highly sensitive HB core‐related antigen assay
Published in Hepatology research (01-09-2022)“…Aims To prevent hepatitis B virus (HBV) reactivation‐related hepatitis, we examined the clinical usefulness of a highly sensitive HB core‐related antigen…”
Get full text
Journal Article -
20
Manual route modification using an oblique method following automatic virtual bronchoscopic navigation
Published in Medicine (Baltimore) (29-04-2022)“…Virtual automatic bronchoscopic navigation (VBN) systems to determine the route to peripheral pulmonary lesions (PPLs) in lung cancer can improve diagnostic…”
Get full text
Journal Article